RxDoctor Payments Data

Jeremy Shore, MD

Orthopaedic Surgery of the Spine · Peabody, MANPI 1598743197

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $140,049 of the $231,506 with a category attached, or 60.5%. 32 manufacturers reported payments, led by Spineology Inc. at 55.9% of the total. Reporting peaked in 2021 at $53,122 and has fallen 60.1% since, to $21,213 in 2025.

$231,506in general payments, 2019–2025

Across 194 payments — averaging $1193.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spineology Inc.$130K
  • Alphatec Spine, Inc$76K
  • Integrity Implants Inc. Dba Accelus$14K
  • Integrity Implants Inc.$6K
  • Life Spine, Inc.$1K
  • Globus Medical$938
  • plus $4K from 26 others

What the payments were for

  • Royalty or licence$140,04960%
  • Consulting fees$36,25016%
  • Speaking & faculty fees$27,25012%
  • Travel & lodging$21,7999%
  • Food & beverage$6,1583%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$231,506 in reported general payments places this provider in the 80th percentile of 28 orthopaedic surgery of the spine providers in Massachusetts.

See all orthopaedic surgery of the spine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$240,079
Medicare patients
668
Services billed
2,439

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib15$242
Prednisone69$239
Oxycodone Hcl16$82
Meloxicam11$48

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Peabody

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →